Medical Therapy of Heart Failure with Reduced Ejection Fraction—A Call for Comparative Research

The armamentarium of therapies for patients with heart failure and reduced ejection fraction (HFREF) has increase substantially with the introduction of Angiotensin Receptor Neprilysin Inhibitor (ARNi), sodium glucose cotransport inhibitors (SGLTis), ivabradine, and Vericinguat, bringing to seven th...

Descripción completa

Detalles Bibliográficos
Autores principales: Cotter, Gad, Davison, Beth A., Mebazaa, Alexandre, Takagi, Koji, Novosadova, Maria, Freund, Yonathan, Cohen-Solal, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122403/
https://www.ncbi.nlm.nih.gov/pubmed/33919005
http://dx.doi.org/10.3390/jcm10091803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122403/
https://www.ncbi.nlm.nih.gov/pubmed/33919005
http://dx.doi.org/10.3390/jcm10091803

Ejemplares similares